Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015

Similar documents
Profiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola

Structural Variation and Medical Genomics

MicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL

Harmesh Naik, MD. Hope Cancer Clinic PERSONALIZED CANCER TREATMENT USING LATEST IN MOLECULAR BIOLOGY

The Biology and Genetics of Cells and Organisms The Biology of Cancer

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser

Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD

Biochemistry of Cancer and Tumor Markers

Chapter 4 Cellular Oncogenes ~ 4.6 -

Section D: The Molecular Biology of Cancer

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl

Molecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC

CELL BIOLOGY - CLUTCH CH CANCER.

Breast cancer: Molecular STAGING classification and testing. Korourian A : AP,CP ; MD,PHD(Molecular medicine)

Introduction to Genetics

Cancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz October 11, 2013

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

Session 4 Rebecca Poulos

Introduction to Cancer Bioinformatics and cancer biology. Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015

The mutations that drive cancer. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

Early Embryonic Development

Regarding techniques of proteomics, there is:

microrna Presented for: Presented by: Date:

Genomic Instability. Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute. RPN-530 Oncology for Scientist-I October 18, 2016

Molecular classification of breast cancer implications for pathologists. Sarah E Pinder

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Introduction to Systems Biology of Cancer Lecture 2

RNA-seq Introduction

oncogenes-and- tumour-suppressor-genes)

Genomic Medicine: What every pathologist needs to know

Genomic tests to personalize therapy of metastatic breast cancers. Fabrice ANDRE Gustave Roussy Villejuif, France

FISH mcgh Karyotyping ISH RT-PCR. Expression arrays RNA. Tissue microarrays Protein arrays MS. Protein IHC

CELL CYCLE REGULATION AND CANCER. Cellular Reproduction II

mirna Dr. S Hosseini-Asl

DOES THE BRCAX GENE EXIST? FUTURE OUTLOOK

Cell Division. non-mitotic cell. Dividing (mitotic) cell. (This movie has been sped up.) These chromosomes have been marked with RED fluorescence.

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Breast cancer classification: beyond the intrinsic molecular subtypes

Supplementary Figure 1: Comparison of acgh-based and expression-based CNA analysis of tumors from breast cancer GEMMs.

Developing Better Medicine

Ch. 18 Regulation of Gene Expression

Predictive Assays in Radiation Therapy

ABS04. ~ Inaugural Applied Bayesian Statistics School EXPRESSION

p53 and Apoptosis: Master Guardian and Executioner Part 2

GENE EXPRESSION. Amoeba Sisters video 3pk9YVo. Individuality & Mutations

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber

Session 4 Rebecca Poulos

609G: Concepts of Cancer Genetics and Treatments (3 credits)

Biomarker development in the era of precision medicine. Bei Li, Interdisciplinary Technical Journal Club

Integrated Analysis of Copy Number and Gene Expression

Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY

Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY

Viruses Tomasz Kordula, Ph.D.

Chapter 18- Oncogenes, tumor suppressors & Cancer

Development of Carcinoma Pathways

Lecture 1: Carcinogenesis

Introduction to Cancer Biology

Cancer and Gene Regulation

ncounter Assay Automated Process Immobilize and align reporter for image collecting and barcode counting ncounter Prep Station

Cancer genetics

OMICS Journals are welcoming Submissions

Central Dogma. Central Dogma. Translation (mrna -> protein)

genomics for systems biology / ISB2020 RNA sequencing (RNA-seq)

Notes 7.5: Mitosis Gone Wrong

Type: Evidence Based Evidence Quality: High Strength of Recommendation: Strong

micrornas (mirna) and Biomarkers

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Genomic instability. Amin Mahpour

Neoplasia 2018 lecture 11. Dr H Awad FRCPath

Cancer Genomics (Current technologies & clinical implication)

The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis

The Cancer Genome Atlas

Outline. Outline. Phillip G. Febbo, MD. Genomic Approaches to Outcome Prediction in Prostate Cancer

Cancer and Gene Alterations - 1

number Done by Corrected by Doctor Maha Shomaf

A class of genes that normally suppress cell proliferation. p53 and Rb..ect. suppressor gene products can release cells. hyperproliferation.

Contemporary Classification of Breast Cancer

Genes, Aging and Skin. Helen Knaggs Vice President, Nu Skin Global R&D

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Liposarcoma*Genome*Project*

COST ACTION CA IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN)

Triple Negative Breast Cancer

Supplementary Figure 1: High-throughput profiling of survival after exposure to - radiation. (a) Cells were plated in at least 7 wells in a 384-well

Profili di espressione genica

Chapter 1 : Genetics 101

Gene Expression. From a gene to a protein

Role of Genomic Profiling in (Minimally) Node Positive Breast Cancer

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

CDH1 truncating alterations were detected in all six plasmacytoid-variant bladder tumors analyzed by whole-exome sequencing.

Screening for novel oncology biomarker panels using both DNA and protein microarrays. John Anson, PhD VP Biomarker Discovery

Clasificación Molecular del Cáncer de Próstata. JM Piulats

Mutations. Any change in DNA sequence is called a mutation.

FILE // WHAT ARE TUMOR SUPPRESSOR GENES EBOOK

Personalised medicine: Past, present and future

General Biology 1004 Chapter 11 Lecture Handout, Summer 2005 Dr. Frisby

New Opportunities in Cancer Research National Academy of Sciences Advancing Health Research in Poland and the United States December 3, 2009

USCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest

Transcription:

Goals/Expectations Computer Science, Biology, and Biomedical (CoSBBI) We want to excite you about the world of computer science, biology, and biomedical informatics. Experience what it is like to be a scientist. train next gen of scientists Answer a question/ask a question Reading papers and Discussing (Journal Clubs) how scientists learn roundtables how scientists learn career prepare you for success regardless of choice cameos professional development pipeline comeback we will pay you. we will guide you through decisions and steps to lead to a career. Year wide involvement letters of recommendation opportunity science fairs! $ scholarships lines on your applications spread the word. DO THE SURVEYS AND ALWAYS TELL US HOW TO IMPROVE KEEP IN CONTACT LinkedIn? Biology of AND David Boone Outline 1

Goals Understand why treatment is difficult. Learn how changes in genome and/or expression can affect proliferation/death. looking at signaling schematic be able to identify what a certain mutation might do. Define oncogenes and tumor suppressors. Define two ways of gathering omics data Be able to analyze heat maps and Kaplan Meier Curve Describe how informatics is impacting personalized medicine. Outline How is different from a bacterial infection? Normal Term used to describe 100s or 1000s of distinct neoplastic disorders caused by your own cells growing out of control. 2

Metastasis Spreading of from one organ to another The many steps of Metastasis occur through clonal selection and the accumulation of different mutations How do we make sense of? Fidler 2003 nature reviews Determine what causes it. What changes occur during the initiation and progression of? How are ous cells different from normal cells? Elucidate which patients will respond to what therapies. Pattern recognition and logic problems Sequencing Biomarkers 3

Outline The Central Dogma of Biology DNA RNA Protein Structure is very important replication transcription/translation info to create proteins 23 chromosomes 3.2 billion base pairs ~20000 genes (1.5% of genome) Central Dogma Important genes in No T s replaced with U s Translation start Translation stop Oncogenes genes that encode for proteins that have the potential to cause. like a gas pedal they make the cells divide more frequently or survive when they shouldn t. turned on by activating mutations, amplifications, and overexpression. ex. c Myc, IGF1R, Ras (growth factors, signaling molecules, transcription factors) 4

Important genes in Survival IGF1R is an important oncogene in BC Can you pick out any other potential oncogenes? Tumor Suppressors genes that encode for proteins that prevent tumor development. like a break pedal they prevent proliferation and initiate cell death if there are problems like DNA damage. They keep proliferation and oncogenes in check. Stop the cell cycle, induce apoptosis, DNA repair, etc. turned off by inactivating mutations, deletions, and lack of expression. ex. p53, BRCA1/2, PTEN, RB too much too much Myc (oncogene) is one of the most frequent amplifications in BC. p53 (tumor suppressor) is one of the most frequently mutated or lost genes in BC. Outline 5

Genetic alterations (All mutations are not equal) Point mutations DNA Frameshift mutation RNA Protein K A * Genetic alterations Genomic alterations Point mutations Duplications or amplifications Point mutations Duplications or amplifications Deletions Myc Myc Myc p53 6

Genomic alterations Point mutations Duplications or amplifications Deletions Insertions/ Inversions Genomic alterations Point mutations Duplications or amplifications Deletions Insertions/ Inversions Translocations Expression alterations outside of the genome Overexpression. ex. Myc (high mitogenic signaling results in high expression of unmutated Myc. Epigenetic silencing ex. methylation Outline/Summary Biology of 7

Outline Now we know a lot about individual genes, but how do we study global genetic or expression changes? Microarrays Hybridization based (complementary base pairing) Comparative Genome Hybridization (CGH) or SNP arrays for known DNA variants and copy number changes. mrna Expression arrays for RNA expression. Next Gen sequencing Sequence based can be used for DNA or RNA can detect mutations, copy number changes, and expression differences. Microarrays Next gen sequencing Used for: 1) Gene expression 2) Copy number changes whole transcript expression array covers 28,869 wellannotated genes with 764,885 distinct probes. affy 6.0 SNP chip 906,000 SNPs and ~ 1,000,000 ADVANTAGES: Relatively cheap Analyze all known genes Analysis is relatively easy DISADVANTAGES Cannot detect novel genes, mutations, or copy number changes Human Genome Project took ~13 years and cost ~3 billion dollars. 3billion bases Now in a few weeks for less than a few thousand dollars, we can sequence a genome. Advantages No limitation on novel detections simultaneously discover expression or copy number changes AND mutations. Disadvantages: expensive analysis is complex and difficult (but not for CoSBBI scholars!) 8

The sequencing boom The Genome Atlas (TCGA) The Genome Atlas (TCGA) is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of through the application of genome analysis technologies, including largescale genome sequencing. 33 s 275 million dollars 11000 patients 2700 publications since started in 2006 RNA expression (RNAseq and microarray) Exome sequencing (mutation) Whole genome (for some) Copy number Methylation mirna expression $1000 genome ENCODE (encyclopedia of DNA elements) The human genome project or our generation Build a comprehensive parts list of functional elements in the human genome. Outline 9

Pattern recognition/logic Problems HOW DO WE MAKE SENSE OF IT ALL?!?! Personalized medicine Breast IT WORKS!! Historically classified based on tumor size, nodal involvement, invasion, histology, etc. More recently genomics and transcriptomics have provided clues to what drives tumor initiation and progression and has the potential to divide patients into separate groups that might respond to different therapies. Bayer Sørlie T et al. PNAS 2001;98:10869-10874 10

Gene Expression Patterns Reveal Novel Breast Sub types Gene expression patterns of 85 experimental samples representing 78 carcinomas, three benign tumors, and four normal tissues, analyzed by hierarchical clustering using the 476 cdna intrinsic clone set. Overall and relapse-free survival analysis of the 49 breast patients, uniformly treated in a prospective study, based on different gene expression classification. Personalized medicine WORKS!!!! patient gene Finding Patterns!!! ER ER+ low high basal HER2+ Normal basal like luminal A luminal B Sørlie T et al. PNAS 2001;98:10869-10874 Sørlie T et al. PNAS 2001;98:10869-10874 2001 by National Academy of Sciences Gene expression use in the clinic Mammaprint approved by FDA 70 gene signature for patients with node negative and ER+ tumors compared to conventional classification in ~300 patients 87 would have been treated differently. 67 were determined high risk by conventional methods and were given chemo but by Mammaprint were classified low risk. Followed patients for 10 yrs and Mammaprint was more accurate Oncotype PAM50 All good for deciding chemo vs. endocrine therapy, but still need classifications for ERtumors Summary is different than other diseases because it is really 100s or 1000s of diseases and is your own cells gone bad. Oncogenes cause hyperactive mutation, amplification Tumor Suppressors prevent Prevent cell cycle progression Induce cell death DNA repair lost or turned off mutation, deletion, methylation Different types of alterations Somatic mutation amplification deletion methylation Global analysis Microarray Sequencing Personalized Medicine Biomarker and KM curve 11

1 2 3 4 5 A low high 12